Designing chitosan-dextran sulfate nanoparticles using charge ratios.
The purpose of this study was to examine the effect of charge ratio on the formation and properties of the chitosan (CS)-dextran sulfate (DS) nanoparticles developed for the delivery of water-soluble small and large molecules, including proteins. Rhodamine 6G (R6G) and bovine serum albumin (BSA) were chosen as model molecules. CS-DS nanoparticles were formulated by a complex coacervation process under mild conditions. The influence of formulation and process variables, including the charge ratio of the 2 ionic polymers, on particle size, zeta potential, and nanoparticle entrapment of R6G and BSA was studied. The in vitro release of R6G and BSA was also evaluated, and the integrity of BSA in the release fraction was assessed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Depending on the concentration and charge ratio of DS and CS, nanoparticles with varied size (>or=244 nm) and zeta potential (-47.1-60 mV) were obtained. High entrapment efficiency (98%) was achieved for both R6G and BSA when the charge ratio of the 2 ionic polymers was greater than 1.12. The release of both R6G and BSA from nanoparticles was based on the ion-exchange mechanism. BSA showed much slower continuous release for up to 7 days while still maintaining its integrity for an extended period. The CS-DS nanoparticles developed based on the modulation of charge ratio show promise as a system for controlled delivery of both small and large molecules, including proteins.
Chen
Yan
Y
School of Pharmacy, Curtin University of Technology, GPO Box U1987, Perth, Western Australia. y.chen@curtin.edu.au
Mohanraj
Vellore J
VJ
Wang
Fang
F
Benson
Heather A E
HA
D002626:Chemistry, Pharmaceutical; D048271:Chitosan / Q000737:chemistry*; D003692:Delayed-Action Preparations; D016264:Dextran Sulfate / Q000737:chemistry*; D004337:Drug Carriers; D004339:Drug Compounding; D007474:Ion Exchange; D053758:Nanoparticles; D010316:Particle Size; D011506:Proteins / Q000737:chemistry*; D012235:Rhodamines / Q000737:chemistry; D012710:Serum Albumin, Bovine / Q000737:chemistry; D012995:Solubility; D013499:Surface Properties; D013678:Technology, Pharmaceutical / Q000379:methods; D013997:Time Factors
D003692:Delayed-Action Preparations; D004337:Drug Carriers; D011506:Proteins; D012235:Rhodamines; C026188:rhodamine 6G; D012710:Serum Albumin, Bovine; D048271:Chitosan; D016264:Dextran Sulfate